DCLK1 and familial pancreatic carcinoma: The upregulation of glycolysis can promote reactive oxygen species (ROS) production, targeting DCLK1 (doublecortin-like kinase 1) to promote the stem-like phenotype and epithelial–mesenchymal transition of gemcitabine-resistant pancreatic cancer cells [26].